Related Experiment Videos
The high prevalence of HLA-B5 in Behçet's disease
Clinical and Experimental Immunology
|November 1, 1977
Abstract:
Sixteen of the nineteen (84%) patients with Behçet's disease in Turkey had HLA-B5; the prevalence of HLA-B5 among 150 controls was 27%.
Insights
Behçet's disease, a rare autoimmune disorder, is strongly associated with the HLA-B5 genetic marker in Turkish patients. This finding suggests a potential genetic link in disease development.
Area of Science:
- Immunogenetics
- Rheumatology
- Human Genetics
Background:
- Behçet's disease is a multisystem inflammatory disorder with a complex etiology.
- Genetic factors are implicated in the susceptibility to Behçet's disease.
Purpose of the Study:
- To investigate the association between the HLA-B5 antigen and Behçet's disease in a Turkish population.
- To determine the prevalence of HLA-B5 in Behçet's disease patients compared to healthy controls.
Main Methods:
- Case-control study design.
- Human Leukocyte Antigen (HLA) typing was performed on patients with Behçet's disease and healthy controls.
- Prevalence of HLA-B5 was calculated for both groups.
Main Results:
- A significantly higher prevalence of HLA-B5 was observed in patients with Behçet's disease (84%) compared to the control group (27%).
- Out of nineteen Behçet's disease patients, sixteen tested positive for HLA-B5.
Conclusions:
- The HLA-B5 antigen shows a strong association with Behçet's disease in the Turkish population.
- This genetic marker may play a role in the pathogenesis or susceptibility to Behçet's disease.